Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
| Revenue (Most Recent Fiscal Year) | $2.09B |
| Net Income (Most Recent Fiscal Year) | $-304.90M |
| PE Ratio (Current Year Earnings Estimate) | 31.55 |
| PE Ratio (Trailing 12 Months) | 31.39 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.31 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 8.99 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 24.57 |
| Pre-Tax Margin (Trailing 12 Months) | -14.11% |
| Net Margin (Trailing 12 Months) | -25.06% |
| Return on Equity (Trailing 12 Months) | 22.56% |
| Return on Assets (Trailing 12 Months) | 10.00% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.17 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.62 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.67 |
| Inventory Turnover (Trailing 12 Months) | 2.38 |
| Book Value per Share (Most Recent Fiscal Quarter) | $17.45 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.36 |
| Earnings per Share (Most Recent Fiscal Year) | $4.40 |
| Diluted Earnings per Share (Trailing 12 Months) | $-9.17 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 54.22M |
| Free Float | 48.96M |
| Market Capitalization | $8.51B |
| Average Volume (Last 20 Days) | 0.72M |
| Beta (Past 60 Months) | 1.23 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 9.70% |
| Percentage Held By Institutions (Latest 13F Reports) | 85.96% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |